Retractable Technologies (RVP) Cash from Investing Activities (2010 - 2026)
Retractable Technologies' (RVP) quarterly Cash from Investing Activities came in at $1.7 million in Q1 2026, up 122.01% YoY from $762239.0 in Q1 2025, and up 1575.37% on a QoQ basis from -$114698.0 in Q4 2025.
Retractable Technologies (RVP) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Cash from Investing Activities data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 122.01% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 40.4% YoY) and the FY2025 annual result came in at $6.0 million, up 63.51% from the prior year.
- Cash from Investing Activities climbed to $1.7 million in Q1 2026, from -$114698.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $3.5 million in Q2 2025 to a low of -$17.6 million in Q2 2022.
- A 5-year average of -$1.8 million and a median of -$322324.0 in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 1197.4% in 2025, down 107.35% in 2025.
- Tracing RVP's Cash from Investing Activities over 5 years: stood at -$3.1 million in 2022, then soared by 88.6% to -$347758.0 in 2023, then soared by 548.55% to $1.6 million in 2024, then plunged by 107.35% to -$114698.0 in 2025, then jumped by 1575.37% to $1.7 million in 2026.
- The last three Cash from Investing Activities figures came in at $1.7 million (Q1 2026), -$114698.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Retractable Technologies | 21.67 Mn | -18.20 Mn | 190,852.00 | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | -114,698.00 |
| Dec 31, 2025 | -114,698.00 |
| Sep 30, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Mar 31, 2025 | 762,239.00 |
| Mar 31, 2025 | 762,239.00 |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | -322,324.00 |
| Jun 30, 2024 | -322,324.00 |
| Mar 31, 2024 | -502,722.00 |
| Mar 31, 2024 | -502,722.00 |
| Dec 31, 2023 | -347,758.00 |
| Dec 31, 2023 | -347,758.00 |